APA
Hamblin P. S., Wong R., Ekinci E. I., Fourlanos S., Shah S., Jones A. R., Hare M. J. L., Calder G. L., Epa D. S., George E. M., Giri R., Kotowicz M. A., Kyi M., Lafontaine N., MacIsaac R. J., Nolan B. J., O'Neal D. N., Renouf D., Varadarajan S., Wong J., Xu S. & Bach L. A. (20200520). SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. : The Journal of clinical endocrinology and metabolism.
Chicago
Hamblin Peter S, Wong Rosemary, Ekinci Elif I, Fourlanos Spiros, Shah Sonali, Jones Alicia R, Hare Matthew J L, Calder Genevieve L, Epa Dilan Seneviratne, George Elizabeth M, Giri Rinky, Kotowicz Mark A, Kyi Mervyn, Lafontaine Nicole, MacIsaac Richard J, Nolan Brendan J, O'Neal David N, Renouf Debra, Varadarajan Suresh, Wong Jennifer, Xu Sylvia and Bach Leon A. 20200520. SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. : The Journal of clinical endocrinology and metabolism.
Harvard
Hamblin P. S., Wong R., Ekinci E. I., Fourlanos S., Shah S., Jones A. R., Hare M. J. L., Calder G. L., Epa D. S., George E. M., Giri R., Kotowicz M. A., Kyi M., Lafontaine N., MacIsaac R. J., Nolan B. J., O'Neal D. N., Renouf D., Varadarajan S., Wong J., Xu S. and Bach L. A. (20200520). SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. : The Journal of clinical endocrinology and metabolism.
MLA
Hamblin Peter S, Wong Rosemary, Ekinci Elif I, Fourlanos Spiros, Shah Sonali, Jones Alicia R, Hare Matthew J L, Calder Genevieve L, Epa Dilan Seneviratne, George Elizabeth M, Giri Rinky, Kotowicz Mark A, Kyi Mervyn, Lafontaine Nicole, MacIsaac Richard J, Nolan Brendan J, O'Neal David N, Renouf Debra, Varadarajan Suresh, Wong Jennifer, Xu Sylvia and Bach Leon A. SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. : The Journal of clinical endocrinology and metabolism. 20200520.